Y Intercept Hong Kong Ltd Invests $6.77 Million in Astera Labs, Inc. $ALAB

Y Intercept Hong Kong Ltd bought a new position in Astera Labs, Inc. (NASDAQ:ALAB) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 34,569 shares of the company’s stock, valued at approximately $6,769,000.

A number of other large investors also recently made changes to their positions in ALAB. Bernard Wealth Management Corp. purchased a new stake in shares of Astera Labs in the second quarter valued at $36,000. Clearstead Trust LLC raised its stake in Astera Labs by 46,100.0% during the second quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock worth $42,000 after purchasing an additional 461 shares during the period. Advisors Asset Management Inc. boosted its holdings in shares of Astera Labs by 68.6% in the 2nd quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock valued at $43,000 after purchasing an additional 194 shares during the last quarter. Manchester Capital Management LLC grew its stake in shares of Astera Labs by 141.5% during the 2nd quarter. Manchester Capital Management LLC now owns 483 shares of the company’s stock valued at $44,000 after buying an additional 283 shares during the period. Finally, Ameritas Advisory Services LLC acquired a new stake in shares of Astera Labs during the 2nd quarter worth $64,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Analyst Ratings Changes

A number of research firms have issued reports on ALAB. Jefferies Financial Group reissued a “buy” rating on shares of Astera Labs in a research report on Wednesday, December 3rd. Northland Securities lifted their price target on shares of Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a research report on Tuesday, December 9th. Needham & Company LLC increased their target price on Astera Labs from $205.00 to $220.00 and gave the company a “buy” rating in a research note on Wednesday, November 5th. TD Cowen restated a “hold” rating on shares of Astera Labs in a research note on Wednesday, November 5th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Astera Labs in a research note on Wednesday. Fifteen research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $190.63.

Astera Labs Price Performance

Shares of ALAB opened at $169.66 on Friday. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90. The business’s fifty day moving average price is $161.80 and its 200 day moving average price is $169.34. The stock has a market capitalization of $28.66 billion, a PE ratio of 152.85, a price-to-earnings-growth ratio of 2.31 and a beta of 1.50.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The business had revenue of $230.58 million during the quarter, compared to analyst estimates of $206.42 million. During the same quarter in the previous year, the firm posted $0.23 EPS. The business’s revenue for the quarter was up 103.9% compared to the same quarter last year. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, research analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Insider Activity

In other Astera Labs news, CFO Michael Truett Tate sold 11,430 shares of the company’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $1,653,806.70. Following the completion of the sale, the chief financial officer directly owned 192,297 shares in the company, valued at $27,823,452.93. This represents a 5.61% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Sanjay Gajendra sold 90,459 shares of the business’s stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the completion of the sale, the chief operating officer owned 1,599,750 shares in the company, valued at approximately $231,467,827.50. This trade represents a 5.35% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 576,936 shares of company stock worth $87,409,540 over the last ninety days. 12.50% of the stock is currently owned by company insiders.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.